LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.018
87.86 84.90 558 7680 0.0727 0.3360
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
87.86 84.90 10419 7680 1.3566 1.0961
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
87.86 84.90 9109 7680 1.1860 1.0532
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
87.86 84.90 9224 7680 1.2010 1.0572
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
89.57 84.90 561 7494 0.0749 0.3393
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
89.57 84.90 10658 7494 1.4221 1.1120
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
89.57 84.90 9193 7494 1.2266 1.0642
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
89.57 84.90 9365 7494 1.2496 1.0701
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
91.27 84.90 552 7420 0.0744 0.3368
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
91.27 84.90 11046 7420 1.4886 1.1273
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
91.27 84.90 9292 7420 1.2523 1.0710
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
91.27 84.90 9507 7420 1.2812 1.0783
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
92.98 84.90 523 7257 0.0721 0.3275
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
92.98 84.90 11262 7257 1.5517 1.1417
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
92.98 84.90 8926 7257 1.2299 1.0655
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
92.98 84.90 9641 7257 1.3284 1.0905
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
94.68 84.90 372 7000 0.0531 0.2613
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
94.68 84.90 11571 7000 1.6529 1.1643
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
94.68 84.90 9238 7000 1.3196 1.0891
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
94.68 84.90 9788 7000 1.3982 1.1081
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.031623
2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
2.66 84.90 6 285 0.0210 -0.7798
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
2.66 84.90 726 285 2.5408 2.4066
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
4.36 84.90 1 322 0.0031 -0.9004
MN20160318_Q02
H17